Dry eye is common in children with JRA

Article

Dry eye is common in children with juvenile rheumatoid arthritis (JRA).

Dry eye is common in children with juvenile rheumatoid arthritis (JRA), reveals an investigation in the European Journal of Ophthalmology.

Dr Amany Abdel-Fattah El-Shazly et al., Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt, conducted an evaluation into dry eye on 40 patients with JRA.

The study consisted of 28 girls and 12 boys between the ages of 7 and 12 years. Each patient underwent medical history, clinical examination and a full ophthalmologic evaluation.

Tear filrm break-up time, Schirmer-1 test and corneal fluorescein staining were to test for dry eye. The control gropu consisted of 20 healthy age and sex-matched children.

The results demonstrated that 30 patients presented with consistent findings with dry eye diagnosis. First-degree dryness was found in 20 patients, second-degree dryness in 8 patients and 2 had third-degree dryness.

Dry eye severity tended to be significantly lower in remission, compared to amount of disease activity. The only factor that seemed to affect dry eye parameters was the duration of the disease.

The study authors suggest that all children with JRA should be screened for dry eye as the severity of dry eye is highly correlated with disease activity.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.